Role of c-Fes in normal and neoplastic hematopoiesis

Stem Cells

Volumn 14, Issue 1, 1996, Pages 117-123

  Yates, Karen E ^a   Gasson, Judith C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c Fes; c Fps; Hematopoiesis; Leukemia; Signal transduction; Tyrosine kinase

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; NONHUMAN; ONCOGENE; ONCOGENE C FES; REVIEW; SIGNAL TRANSDUCTION;

AVES; AVIAN RETROVIRUSES; MAMMALIA;

EID: 0030071457     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140117     Document Type: Review

References (66)

1. Bolen JB. Nonreceptor tyrosine protein kinases. Oncogene 1993;8:2025-2031.
2. Punt CJA. Regulation of hematopoietic cell function by protein tyrosine kinase-encoding oncogenes, a review. Leuk Res 1992;16:551-559.
3. Tsygankov A, Bolen J. The Src family of tyrosine protein kinases in hemopoietic signal transduction. STEM CELLS 1993;11:371-380.
4. Barbacid M, Beemon K, Devare SG. Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus. Proc Natl Acad Sci USA 1980;77:5158-5162.
5. Shibuya M, Hanafusa H. Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell 1982;30:787-795.
6. Roebroek AJM, Schalken JA, Verbeek JS et al. The structure of the human c-fes/fps proto-oncogene. EMBO J 1985;4:2897-2903.
7. Wilks AF, Kurban RR. Isolation and structural analysis of murine c-fes cDNA clones. Oncogene 1988;3:289-294.
8. Katzen AL, Montarras D, Jackson J et al. A gene related to the proto-oncogene fps/fes is expressed at diverse times during the life cycle of Drosophila melanogaster. Mol Cell Biol 1991;11:226-239.
9. Alcalay M, Antolini F, Van de Ven WJ et al. Characterization of human and mouse c-fes cDNA clones and identification of the 5′ end of the gene. Oncogene 1990;5:267-275.
10. Hao Q-L, Heisterkamp N, Groffen J. Isolation and sequence analysis of a novel human tyrosine kinase gene. Mol Cell Biol 1989;9:1587-1593.
11. Fischman K, Edman JC, Shackleford GM et al. A murine fer testis-specific transcript (ferT) encodes a truncated Fer protein. Mol Cell Biol 1990;10:146-153.
12. Keshet E, Itin A, Fischman K et al. The testis-specific transcript (ferT) of the tyrosine kinase FER is expressed during spermatogenesis in a stage-specific manner. Mol Cell Biol 1990;10:5021-5025.
13. Greer P, Haigh J, Mbamalu G et al. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 1994;14:6755-6763.
14. Samarut J, Mathey-Prevot B, Hanafusa H. Preferential expression of the c-fps protein in chicken macrophages and granulocytic cells. Mol Cell Biol 1985;5:1067-1072.
15. MacDonald I, Levy J. Pawson T. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol Cell Biol 1985;5:2543-2551.
16. Ferrari S, Torelli U, Selleri L et al. Expression of human c-fes oncogene occurs at detectable levels in myeloid but not in lymphoid cell populations. Br J Haematol 1985;59:21-25.
17. Lanfrancone L, Mannoni P, Pebusque MJ et al. Expression pattern of c-fes oncogene mRNA in human myeloid cells. Int J Cancer 1989;4:35-38.
18. Care A, Mattia G, Montesoro E et al. c-fes expression in ontogenetic development and hematopoietic differentiation. Oncogene 1994;9:739-747.
19. Slamon DJ, deKernion JB, Verma IM et al. Expression of cellular oncogenes in human malignancies. Science 1984;224:256-262.
20. Smithgall TE, Johnston JB, Bustin M et al. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification. JNCI 1991;83:42-46.
21. Yee S-P, Mock D, Greer P et al. Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase. Mol Cell Biol 1989;9:5491-5499.
22. Carmier JF, Samarut J. Chicken myeloid stem cells infected by retroviruses carrying the v-fps oncogene do not require exogenous growth factors to differentiate in vitro. Cell 1986;44:159-165.
23. gag-fps. Mol Cell Biol 1986;6:4396-4408.
24. gag-fps modulates its biological activity. Cell 1984;37:559-568.
25. gag-fps is not required for protein-tyrosine kinase activity or transforming potential. J Virol 1988;62:2016-2025.
26. gag-fps is essential for protein-tyrosine kinase activity. EMBO J 1986;5:69-86.
27. lch in thymopoiesis. EMBO J 1993;12:1671-1680.
28. Sawyers CL, McLaughlin J, Goga A et al. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 1994;77:121-131.
29. Greet P, Meckling-Hansen K, Pawson T. The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransformmg and has restrained protein-tyrosine kinase activity. Mol Cell Biol 1988;8:578-587.
30. Greer P, Maltby V, Rossant J et al. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice. Mol Cell Biol 1990;10:2521-2527.
31. Foster DA, Shibuya M, Hanafusa H. Activation of the transformation potential of the cellular fps gene. Cell 1985;42:105-110.
32. Sodroski JG, Goh GC, Haseltine WA. Tranforming potential of a human proto-oncogene (c-fps/fes) locus. Proc Natl Acad Sci USA 1984;81:3039-3043.
33. Feldman RA, Lowy DR, Vass WC et al. A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene. J Virol 1989;63:5469-5474.
34. Brach MA, Gauer E, Ludwig W-D et al. Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously. Int J Cell Cloning 1991;9:89-94.
35. src myristoylation and membrane association and for cell transformation. Mol Cell Biol 1984;4:1834-1842.
36. Shtivelman E, Lifshitz B, Gale RP et al. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985;315:550-554.
37. c-Fes. J Biol Chem 1994;269:5764-5769.
38. Maru Y, Peters KL, Afar DEH et al. Tyroskine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol Cell Biol 1995;15:835-842.
39. c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism. Biochemistry 1993;32:10519-10525.
40. Lowenstein EJ, Daly RJ, Batzer AG et al. The SH2 and SH3 domain-containmg protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992;70:431-442.
41. Rozakis-Adcock M, McGlade J, Mbamalu G et al. Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992;360:689-692.
42. Pendergast AM, Quilliam LA, Cripe LD et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993;75:175-185.
43. Ferrari S, Donelli A, Manfredini R et al. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Cell Growth Differ 1990;1:543-548.
44. Ferrari S, Manfredini R, Tagliafico E et al. Antiapoptotic effect of c-fes proto-oncogene during granulocytic differentiation. Leukemia 1994;8(Suppl 1):S91-S94.
45. Smithgall TE, Yu G, Glazer RI. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locos and its expression in myelomonocytic cells. J Biol Chem 1988;263:15050-15055.
46. Yu G, Smithgall TE, Glazer RI. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J Biol Chem 1989;264:10276-10281.
47. c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells. Biochemistry 1993;32:6995-7001.
48. Bazan JF. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain. Biochem Biophys Res Commun 1989;164:788-795.
49. Morla AO, Schreurs J, Miyajima A et al. Hematopoietic growth factors activate the tyrosine phosphorylation of distinct sets of proteins in interleukin-3-dependent murine cell lines. Mol Cell Biol 1988;8:2214-2218.
50. Miyajima A. Molecular structure of the IL-3, GM-CSF and IL-5 receptors. Int J Cell Cloning 1992;10:126-134.
51. Watowich SS, Yoshimura A, Longmore GD et al. Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 1992;89:2140-2144.
52. Miyajima A, Mui AL-F, Ogorochi T et al. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993;82:1960-1974.
53. Sato N, Sakamaki K, Terada N et al. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J 1993;12:4181-4189.
54. Ronco LV, Doyle SE, Raines M et al. Conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor-binding subunit essential for tyrosine phosphorylation and proliferation. J Immunol 1995;154:3444-3453.
55. Ronco LV, Silverman SL, Wong SG et al. Identification of conserved amino acids in the human GM-CSF receptor alpha subunit critical for function: evidence for formation of a heterodimeric receptor complex prior to ligand binding. J Biol Chem 1994;269:277-283.
56. Argetsinger LS, Campbell GS, Yang X et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993;74:237-244.
57. c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 1994;14:4335-4341.
58. Silvennoinen O, Witthuhn BA, Quelle FW et al. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 1993;90:8429-8433.
59. Witthuhn BA, Quelle FW, Silvennoinen O et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993;74:227-236.
60. Hanazono Y, Chiba S, Sasaki K et al. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J 1993;12:1641-1646.
61. Hanazono Y, Chiba S, Sasaki K et al. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 1993;81:3193-3196.
62. Yates KE, Lynch MR, Wong SG et al. Human c-FES is a nuclear tyrosine kinase. Oncogene 1995; 10:1239-1242.
63. Wang JY Nuclear protein tyrosine kinases. TIBS 1994;19:373-376.
64. Hao Q-L, Ferris DK, White G et al. Nuclear and cytoplasmic location of the FER tyrosine kinase. Mol Cell Biol 1991;11:1180-1183.
65. Hazan B, Bern O, Carmel M et al. ferT encodes a meiosis-specific nuclear tyrosine kinase. Cell Growth Differ 1993;4:443-449.
66. Huang C-C, Hammond C, Bishop JM. Nucleotide sequence and topography of chicken c-fps: genesis of a retroviral oncogene encoding a tyrosine-specific protein kinase. J Mol Biol 1985;181:175-186.